Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue (NCT07102550)
Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue: A Prospective Non-Randomized Clinical Trial
🩺 Plain-English Summary (8th-Grade Level)
The goal of this single armed, non-randomized, pilot study is to demonstrate that placental tissue grafts are safe in living donor liver transplant and assess their impact on biliary outcomes in adults.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (2 items) and avoid the listed exclusions (7 items).
Location: Cleveland Clinic — Cleveland, Ohio
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Patients who are deemed unsafe for participation for any reason by our multi-disciplinary liver transplant selection committee.
- Patients \< 18 years old
- Patients who cannot provide informed consent
- Patients receiving deceased donor liver transplants, or who are not undergoing Liver transplant (LT)
- Patients who do not wish to participate
- Children, cognitively-impaired persons, pregnant women, students and house staff under the direct supervision of the investigator are considered vulnerable populations and will, therefore, be excluded from participation.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- Cleveland Clinic — Cleveland, Ohio
📞 Contact the Study Coordinator
Phone: (216) 444-0223
Email: allkuse2@ccf.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Liver Transplant
- EVR and EPO for Liver Transplant Tolerance — San Francisco, California
- Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool — Boston, Massachusetts
- US National OCS Liver Perfusion (OLP) Registry — Birmingham, Alabama
- Liver Transplantation With Tregs at MGH — Boston, Massachusetts
- Proteogenomic Monitoring and Assessment of Liver Transplant Recipients — Chicago, Illinois
Explore by condition: All Liver Transplant clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.